Birchview-Capital-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
68
Total Value
115165860
Accession Number
0001618205-25-000002
Form Type
13F-HR
Manager Name
Birchview-Capital-Lp
Data Enrichment
91% identified
62 identified6 unidentified

Holdings

68 positions • $115.2M total value
Manager:
Search and click to pin securities to the top
Page 2 of 4
Stoke Therapeutics, Inc.
Shares:210.0K
Value:$1.4M
% of Portfolio:1.2% ($1.4M/$115.2M)
TREACE MEDICAL CONCEPTS, INC.
Shares:164.9K
Value:$1.4M
% of Portfolio:1.2% ($1.4M/$115.2M)
Foghorn Therapeutics Inc.
Shares:310.9K
Value:$1.1M
% of Portfolio:1.0% ($1.1M/$115.2M)
uniQure N.V.
Shares:88.7K
Value:$940.2K
% of Portfolio:0.8% ($940.2K/$115.2M)
KalVista Pharmaceuticals, Inc.
Shares:67.0K
Value:$773.2K
% of Portfolio:0.7% ($773.2K/$115.2M)
Xenon Pharmaceuticals Inc.
Shares:21.0K
Value:$704.5K
% of Portfolio:0.6% ($704.5K/$115.2M)
Axsome Therapeutics, Inc.
Shares:6.0K
Value:$699.8K
% of Portfolio:0.6% ($699.8K/$115.2M)
G5269C101
Shares:30.0K
Value:$666.4K
% of Portfolio:0.6% ($666.4K/$115.2M)
HALOZYME THERAPEUTICS, INC.
Shares:10.0K
Value:$638.1K
% of Portfolio:0.6% ($638.1K/$115.2M)
Ultragenyx Pharmaceutical Inc.
Shares:16.0K
Value:$579.4K
% of Portfolio:0.5% ($579.4K/$115.2M)
NovoCure Ltd
Shares:31.0K
Value:$552.4K
% of Portfolio:0.5% ($552.4K/$115.2M)
Scholar Rock Holding Corp
Shares:16.0K
Value:$514.4K
% of Portfolio:0.4% ($514.4K/$115.2M)
ORTHOPEDIATRICS CORP
Shares:20.0K
Value:$492.6K
% of Portfolio:0.4% ($492.6K/$115.2M)
Solid Biosciences Inc.
Shares:128.8K
Value:$476.4K
% of Portfolio:0.4% ($476.4K/$115.2M)
Inhibrx Biosciences, Inc.
Shares:32.1K
Value:$449.2K
% of Portfolio:0.4% ($449.2K/$115.2M)
10x Genomics, Inc.
Shares:50.0K
Value:$436.5K
% of Portfolio:0.4% ($436.5K/$115.2M)
CYTOKINETICS INC
Shares:10.0K
Value:$401.9K
% of Portfolio:0.3% ($401.9K/$115.2M)
SpringWorks Therapeutics, Inc.
Shares:8.3K
Value:$365.4K
% of Portfolio:0.3% ($365.4K/$115.2M)
Pulmonx Corp
Shares:51.0K
Value:$343.2K
% of Portfolio:0.3% ($343.2K/$115.2M)
Candel Therapeutics, Inc.
Shares:60.0K
Value:$339.0K
% of Portfolio:0.3% ($339.0K/$115.2M)